Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration
This medical market and technology report provides a comprehensive discussion of the global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration (including cell-based therapies and tissue scaffolds and grafts). Geographic markets covered by this analysis include the US, Japan, five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW), which includes all other countries.
This report provides the following useful information:
- prevalence of sports injuries
- prevalence of osteoarthritis
- product portfolios offered by leading manufacturers
- new technologies under development
- global market forecasts, by region
- analyses of the top competitors and their market shares.